Innospec Inc. $IOSP Stake Boosted by ProShare Advisors LLC

ProShare Advisors LLC grew its position in shares of Innospec Inc. (NASDAQ:IOSP) by 46.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 118,767 shares of the specialty chemicals company’s stock after acquiring an additional 37,535 shares during the quarter. ProShare Advisors LLC owned 0.48% of Innospec worth $11,321,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in IOSP. BlackRock Inc. purchased a new position in Innospec during the second quarter worth about $356,596,000. Western Standard LLC bought a new stake in Innospec in the 2nd quarter worth about $19,276,000. Hsbc Holdings PLC purchased a new stake in Innospec in the 2nd quarter valued at about $1,936,000. Arrowstreet Capital Limited Partnership increased its stake in Innospec by 196.5% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 18,497 shares of the specialty chemicals company’s stock valued at $1,351,000 after buying an additional 12,259 shares during the last quarter. Finally, Bank of America Corp DE purchased a new stake in Innospec in the 2nd quarter valued at about $19,187,000. Institutional investors own 96.64% of the company’s stock.

Key Innospec News

Here are the key news stories impacting Innospec this week:

• Positive Sentiment: Third-quarter adjusted and GAAP EPS were both $1.29, above the $1.26 consensus and up from $1.12 a year earlier. The company said all businesses contributed to revenue and operating-income growth, with continued strength in Fuel Specialties and double-digit operating-income growth in Performance Chemicals and Oilfield Services. Innospec third-quarter results
• Positive Sentiment: Innospec raised its annual dividend by 9% and declared a semiannual payment of $0.94 per share for the second half of 2026, payable November 25 to shareholders of record November 17. Dividend announcement
• Positive Sentiment: The company generated $17.4 million in operating cash flow, and net cash improved to $251.9 million, supporting its financial flexibility. Innospec third-quarter results
• Negative Sentiment: Revenue rose 7.2% year over year to $473.6 million but missed analyst expectations of $479.17 million, a shortfall that could offset some of the positive earnings news. Innospec Q3 earnings and revenue

Innospec Price Performance

NASDAQ IOSP opened at $99.23 on Wednesday. The business’s fifty day moving average is $96.24 and its 200-day moving average is $84.60. The stock has a market capitalization of $2.44 billion, a price-to-earnings ratio of 20.15, a PEG ratio of 2.65 and a beta of 0.88. Innospec Inc. has a one year low of $65.51 and a one year high of $102.00.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings results on Tuesday, November 3rd. The specialty chemicals company reported $1.29 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.03. Innospec had a net margin of 6.60% and a return on equity of 9.22%. The company had revenue of $473.60 million during the quarter, compared to analyst estimates of $479.17 million. During the same quarter in the prior year, the business earned $1.12 earnings per share. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. Research analysts expect that Innospec Inc. will post 5.01 EPS for the current fiscal year.

Innospec Announces Dividend

The business also recently announced a dividend, which will be paid on Wednesday, November 25th. Shareholders of record on Tuesday, November 17th will be paid a $0.94 dividend. This represents a yield of 189.0%. The ex-dividend date is Tuesday, November 17th. Innospec’s payout ratio is presently 37.55%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on IOSP. Seaport Research Partners restated a “buy” rating and issued a $110.00 target price on shares of Innospec in a research note on Thursday, August 6th. Weiss Ratings raised Innospec from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Finally, Wall Street Zen downgraded Innospec from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 26th. Two analysts have rated the stock with a Hold rating. Based on data from MarketBeat, Innospec presently has an average rating of “Hold”.

Innospec Profile

Innospec Inc (NASDAQ: IOSP) is a global specialty chemicals company that develops, manufactures and markets products used in the fuel, oilfield, personal care and industrial markets. The company serves customers through a portfolio of chemical additives, formulations and technical services designed to improve product performance, efficiency and reliability.

Innospec operates through businesses focused on fuel specialties, performance chemicals and oilfield services. Its fuel-related products include fuel additives for gasoline, diesel, marine and other applications, including detergents, lubricity improvers, cetane improvers and other performance-enhancing formulations.